Intelligent bioprocess platform
Ark Biotech has raised $8.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2024.
Ark Biotech's investors include Primary Venture Partners, HCVC, Rob Hayes, Kevin Carter, Natalie Portman.
Ark Biotech is headquartered in Cambridge, United States.
Intelligent bioprocess platform
Ark Biotech is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ark Biotech — Funding & Investors." VCBacked, May 24, 2024, https://www.vcbacked.co/company/ark-biotech. Accessed August 22, 2026.
VCBacked. (2024). Ark Biotech — Funding & Investors. Retrieved August 22, 2026, from https://www.vcbacked.co/company/ark-biotech
{{cite web |title=Ark Biotech — Funding & Investors |url=https://www.vcbacked.co/company/ark-biotech |website=VCBacked |access-date=August 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated